[{"Assets_0_Q1_USD":32937000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":0.39,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":0.95,"EarningsPerShareDiluted_1_Q1_USD":0.94,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":861000000.0,"NetIncomeLossConverted_1_Q1_USD":1574000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q1_USD":4929000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":14535000000.0,"StockholdersEquity_0_Q1_USD":14416000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1671000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1662000000.0,"filed":"20170427","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2017.0","name":"BRISTOL MYERS SQUIBB CO","period":"20170331","qtrs":"0","uom":"USD"}]